Developing a nanotechnology-enabled glaucoma device

VisiPlate is designed to treat open-angle glaucoma
VisiPlate is an investigational implant designed to lower intraocular pressure in patients with open-angle glaucoma
Avisi in the news

Ultrathin Shunt Shows Promising Results in Trial
In an article by Glaucoma Physician, Jim Gallagher reports on the positive six-month results for VisiPlate® from the VITA trial presented by Dr. Eydie Miller-Ellis at the American Glaucoma Society (AGS). This was considered a top paper by the society and presented during the Surgery Day Paper Presentation at AGS. Dr. Miller-Ellis serves as the […]

Next-Gen Avisi Technologies Aims for “One and Done” in a MIGS Device
Some medtech start-ups begin with an inventor with a novel idea; others seek out an unmet clinical need looking for a solution. Avisi Technologies began with market research, that is, a direct appeal to glaucoma specialists to determine what they were missing in their tool kits, and specifically, how the current generation of devices for minimally invasive […]

Avisi Technologies Featured at LSI’s 2024 US Emerging Medtech Summit in Keynote Presentation
Summary of Avisi Involvement as Presenting Company 2024 and 2023 Panel Representation Avisi Technologies returned to the 2024 US Emerging Medtech Summit with updates about the development of VisiPlate, a nanotechnology-enabled aqueous shunt for the treatment of glaucoma. Avisi generated buzz in the Life Science Intelligence (LSI) community by announcing exclusive clinical data, showing promising […]